Evolving treatment modalities for immune thrombocytopenia in adults

The management of patients with relapsed or refractory immune thrombocytopenia (ITP) remains challenging for hematologists. While there are a multitude of drugs available, it is largely an individualized management based on patient preferences, side effects, previous treatment received, and response...

Descripción completa

Detalles Bibliográficos
Autores principales: Khadka, Sushmita, Kasireddy, Vineela, Dhakal, Pravash Kumar, Dadiboyina, Chandrakala
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850435/
https://www.ncbi.nlm.nih.gov/pubmed/33552432
http://dx.doi.org/10.1080/20009666.2020.1843237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850435/
https://www.ncbi.nlm.nih.gov/pubmed/33552432
http://dx.doi.org/10.1080/20009666.2020.1843237

Ejemplares similares